**Question:** Latest (most recent) oral direct thrombin inhibitor is -

A. Dabigatran
B. Rivaroxaban
C. Edoxaban
D. Apixaban

**Correct Answer:** D. Apixaban

**Core Concept:** Oral direct thrombin inhibitors are a class of antithrombotic medications that directly inhibit thrombin, a key enzyme in the coagulation cascade.

**Why the Correct Answer is Right:** Apixaban is an oral direct thrombin inhibitor that belongs to the group of direct oral anticoagulants (DOACs). DOACs are a newer generation of anticoagulants that directly inhibit specific components of the coagulation cascade, reducing the risk of blood clots without the need for routine monitoring of coagulation parameters. Apixaban specifically targets thrombin, an enzyme that converts fibrinogen to fibrin, thus promoting clot formation.

**Why Each Wrong Option is Incorrect:**

A. Dabigatran is another oral direct thrombin inhibitor but is not the most recent in comparison to Apixaban.
B. Rivaroxaban is a direct factor Xa inhibitor, not a direct thrombin inhibitor like Apixaban.
C. Edoxaban is another direct factor Xa inhibitor, not a direct thrombin inhibitor like Apixaban.

**Why Apixaban is the Correct Answer:** Apixaban is the most recent oral direct thrombin inhibitor among the given options. It was approved by the US Food and Drug Administration in 2008 and has gained significant popularity due to its efficacy and convenience. Apixaban is commonly used in the prevention and treatment of deep vein thrombosis (DVT), pulmonary embolism (PE), stroke prevention in non-valvular atrial fibrillation (AF), and prevention of venous thromboembolism (VTE) following hip or knee replacement surgery.

**Clinical Pearl:** Apixaban is a valuable option for the management of these conditions, offering a convenient oral administration route with fewer monitoring requirements compared to traditional anticoagulants like warfarin. However, its use should be carefully balanced against potential risks (e.g., bleeding complications) and individual patient factors (age, renal function, etc.) to ensure safe and effective therapy.